Subscribe
shutterstock_676034119_testing
Testing / Shutterstock.com
10 March 2022AmericasMuireann Bolger

FujiFilm sues Butterfly Network over ultrasound patents

A subsidiary of Tokyo-based FujiFilm has announced that it has filed a patent infringement lawsuit against ultrasound machine maker Butterfly Network.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York